Gossamer Bio, Inc. (GOSS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 708.41M |
| Enterprise Value | 873.58M |
| P/E Ratio | -0.31 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.87 |
| Price/Book Ratio | -0.59 |
| Enterprise/Revenue | 0.74 |
| Enterprise/EBITDA | -0.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | -1.59 |
| Operating Margin | -1.4 |
AD
Management Effectiveness
| Return On Assets | -1.94 |
| Return On Equity | 1 |
Income Statement
| Revenue | 48.47M |
| Revenue/Share | 12.01 |
| Gross Profit | 47.47M |
| EBITDA | -158.47M |
| Net Income | -170.37M |
| Diluted EPS | -59.64 |
Balance Sheet
| Total Cash | 51.19M |
| Total Cash/Share | 7.84 |
| Total Debt | 40.85M |
| Total Debt/Equity | -0.33 |
| Current Ratio | 0.6 |
| Book Value Per Share | -18.8 |
Price History
| 52-Week Change | -94.62 |
| 52-Week High | 309.6 |
| 52-Week Low | 8.29 |
| Moving Average 50 Days | 10.71 |
| Moving Average 200 Days | 34.11 |
Statistics
| Average Volume | 258,066 |
| Shares Outstanding | 6.11M |
| % Held by Institutions | 158.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:80 |
| Last Split Date | September 11, 2026 |
AD
